BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Thomassin L, Armengol-Debeir L, Charpentier C, Bridoux V, Koning E, Savoye G, Savoye-Collet C. Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease. World J Gastroenterol 2017; 23(23): 4285-4292 [PMID: 28694669 DOI: 10.3748/wjg.v23.i23.4285]
URL: https://www.wjgnet.com/1007-9327/full/v23/i23/4285.htm
Number Citing Articles
1
Mary-Louise C. Greer, Stuart A. Taylor. Perianal Imaging in Crohn Disease: Current Status With a Focus on MRI, From the AJR Special Series on Imaging of Inflammation. American Journal of Roentgenology 2022; 218(5) doi: 10.2214/AJR.21.26615
2
Giulio Aniello Santoro, Christian Raymond S. Magbojos, Giovanni Maconi, Iwona Sudoł-Szopińska. Pelvic Floor Disorders. 2021;  doi: 10.1007/978-3-030-40862-6_81
3
Viviane Lin, Seyma Gögenur, Frederik Pachler, Tina Fransgaard, Ismail Gögenur. Risk Prediction for Complications in Inflammatory Bowel Disease Surgery: External Validation of the American College of Surgeons’ National Surgical Quality Improvement Program Surgical Risk Calculator. Journal of Crohn's and Colitis 2023; 17(1) doi: 10.1093/ecco-jcc/jjac114
4
Marion Chambaz, Mikael Verdalle-Cazes, Charlotte Desprez, Lucie Thomassin, Cloé Charpentier, Sébastien Grigioni, Laura Armengol-Debeir, Valérie Bridoux, Guillaume Savoye, Céline Savoye-Collet. Deep remission on magnetic resonance imaging impacts outcomes of perianal fistulizing Crohn’s disease. Digestive and Liver Disease 2019; 51(3) doi: 10.1016/j.dld.2018.12.010
5
Nicolas Richard, Antonin Derinck, Valérie Bridoux, Cloé Charpentier, Céline Savoye Collet, Guillaume Savoye. Which magnetic resonance imaging feature is associated with treatment response in perianal fistulizing Crohn’s disease?. Abdominal Radiology 2024; 49(8) doi: 10.1007/s00261-024-04238-3
6
Corentin Lucas, Myriam Bontonou, Marc Aubry, Eric Ogier-Denis, Guillaume Bouguen, Emmanuelle Becker, Yann Le Cunff, Khan Bahadar Khan. Sequence-robust MRI asymmetry measures for the detection of anoperineal lesions in Crohn’s disease on axial pelvic MRI scans. PLOS One 2026; 21(7) doi: 10.1371/journal.pone.0340243
7
Ye Ma, Runfeng Zhang, Wei Liu, Yinghao Sun, Jingnan Li, Hong Yang, Hong Lv, Yue Li, Bei Tan, Xiyu Sun, Jiaming Qian, Ji Li. Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02676-9
8
Yi Fan Lin, Alicia Truchon, Boris Djoukam Mbuko, Huan Yu Lily Dai, Samuel Sassine, Amélie Damphousse, Sébastien Benali, Mona Beaunoyer, Colette Deslandres, Prévost Jantchou. Factors Associated with Fistulizing Crohn’s Disease in Children at Diagnosis: A Cross-Sectional Study. Inflammatory Bowel Diseases 2026; 32(2) doi: 10.1093/ibd/izaf220
9
Francesca Maccioni, Ludovica Busato, Lorenza Bottino, Alessandro Longhi, Alessandra Valenti, Maddalena Zippi, Carlo Catalano. Comprehensive Imaging Evaluation and Staging of Crohn’s Disease: When and Why to Use Intestinal Ultrasound, MRE, or CTE: Current Guidelines and Future Directions. Diagnostics 2026; 16(6) doi: 10.3390/diagnostics16060882
10
D. Cao, X. Wang, Y. Zhang, K. Qian, N. Yang, M. Zhu, Y. Li, G. Wu, Z. Cui. Total fistula volume predicts surgical outcomes in complex perianal fistulizing Crohn’s disease following fistula-tract laser closure: a single-center retrospective study. Techniques in Coloproctology 2025; 29(1) doi: 10.1007/s10151-024-03094-z
11
Xue-Liang Sun, Shi-Yi Chen, Shan-Shan Tao, Li-Chao Qiao, Hong-Jin Chen, Bo-Lin Yang. Optimized timing of using infliximab in perianal fistulizing Crohn's disease. World Journal of Gastroenterology 2020; 26(14): 1554-1563 doi: 10.3748/wjg.v26.i14.1554
12
David A. Schwartz, Laurent Peyrin-Biroulet, Karen Lasch, Shashi Adsul, Silvio Danese. Efficacy and Safety of 2 Vedolizumab Intravenous Regimens for Perianal Fistulizing Crohn’s Disease: ENTERPRISE Study. Clinical Gastroenterology and Hepatology 2022; 20(5) doi: 10.1016/j.cgh.2021.09.028
13
Xiaohan Yan, Mingming Zhu, Qi Feng, Yunqi Yan, Jiangchen Peng, Xitao Xu, Antao Xu, Zhihua Ran. Evaluating the effectiveness of infliximab on perianal fistulizing Crohn’s disease by magnetic resonance imaging. Gastroenterology Report 2019; 7(1) doi: 10.1093/gastro/goy036
14
Pankaj Garg, Vipul D. Yagnik, Baljit Kaur, Geetha R. Menon, Sushil Dawka. Role of MRI to confirm healing in complex high cryptoglandular anal fistulas: long‐term follow‐up of 151 cases. Colorectal Disease 2021; 23(9) doi: 10.1111/codi.15695
15
Tanya Lee, Eric Yong, Nik S Ding. Radiological outcomes in perianal fistulizing Crohn's disease: A systematic review and meta‐analysis. JGH Open 2020; 4(3) doi: 10.1002/jgh3.12295
16
Sudheer K Vuyyuru, Virginia Solitano, Siddharth Singh, Jurij Hanzel, John K Macdonald, Silvio Danese, Laurent Peyrin Biroulet, Christopher Ma, Vipul Jairath. Scoring Indices for Perianal Fistulising Crohn’s Disease: A Systematic Review. Journal of Crohn's and Colitis 2024; 18(6) doi: 10.1093/ecco-jcc/jjad214
17
Firas Rinawi, Mary-Louise C. Greer, Thomas Walters, Peter C. Church, Amanda Ricciuto, Jacob C. Langer, Anne M Griffiths. Anti TNF treatment of complex perianal fistulas in children without luminal Crohn's disease: Is it an option?. Journal of Pediatric Surgery 2022; 57(11) doi: 10.1016/j.jpedsurg.2022.03.031
18
UEG Week 2018 Poster Presentations. United European Gastroenterology Journal 2018; 6(S8) doi: 10.1177/2050640618792819
19
Arshdeep Singh, Chandan Kakkar, Shreya Garg, Kirti Arora, Vandana Midha, Ramit Mahajan, Satpal Singh Virk, Narender Pal Jain, Dharmatma Singh, Kriti Sood, Ashish Tripathi, Dhruv Gupta, Ishita Gupta Kaushal, Ritu Dhawan Galhotra, Kavita Saggar, Ajit Sood. Clinical and magnetic resonance imaging spectrum of complex perianal fistulizing Crohn’s disease: A cohort study from northern India. Indian Journal of Gastroenterology 2023; 42(5) doi: 10.1007/s12664-023-01399-9
20
Habeeb Habeeb, Lynna Chen, Isabelle De Kock, Gauraang Bhatnagar, Numan Kutaiba, Abhinav Vasudevan, Ashish R Srinivasan. Imaging in perianal fistulising Crohn’s disease: A practical guide for the gastroenterologist. World Journal of Gastroenterology 2025; 31(34): 110611 doi: 10.3748/wjg.v31.i34.110611
21
Nicola S. Fearnhead. Inflammatory Bowel Disease Nursing Manual. 2019;  doi: 10.1007/978-3-319-75022-4_20
22
Parul Tandon, Glara Gaeun Rhee, David Schwartz, Jeffrey D. McCurdy. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn’s Disease: A Systematic Review. Digestive Diseases and Sciences 2019; 64(11) doi: 10.1007/s10620-019-05635-1
23
C. Charpentier, M. Verdalle-Cazes, C. Savoye-Collet. Exploration en imagerie des fistules anales. EMC - Radiologie et imagerie médicale - Abdominale - Digestive 2025; 43(3) doi: 10.1016/S1879-8527(25)49549-5
24
Qi Chen, Lingbo Li, Can Wang, Lichao Qiao, Minna Wu, Weiming Zhu, Bolin Yang, Yuxia Gong. Durable clinical and deep remission with ustekinumab in perianal fistulizing Crohn’s disease: A 2-year retrospective real-world cohort study. Digestive and Liver Disease 2025; 57(11) doi: 10.1016/j.dld.2025.08.091
25
Tanya Lee, Michael A Kamm, Sally Bell, Mark Lust, Steve Brown, Ola Niewiadomski, Chamara Basnayake, Emily Wright, Basil D'Souza, Rodney Woods, Shu Chen Wei, William Connell, Alexander Thompson, Eric Yong, Nik Sheng Ding. Long‐term outcomes of perianal fistulizing Crohn's disease in the biologic era. JGH Open 2021; 5(2) doi: 10.1002/jgh3.12475
26
Laura Sirmai, Anne-Laure Pelletier, Nathalie Gault, Camille Zallot, Guillaume Bouguen, Dominique Bouchard, Pascale Roland Nicaise, Marine Peyneau, Sandrine Sironneau, Marcelo De Carvalho Bittencourt, Antoine Petitcollin, Pedro Fernandez, Xavier Roblin, Laurent Siproudhis, Laurent Abramowitz. Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study. World Journal of Gastroenterology 2022; 28(9): 961-972 doi: 10.3748/wjg.v28.i9.961
27
Bénédicte Caron, Ferdinando D’Amico, Silvio Danese, Laurent Peyrin-Biroulet. Endpoints for Perianal Crohn’s Disease Trials: Past, Present and Future. Journal of Crohn's and Colitis 2021; 15(8) doi: 10.1093/ecco-jcc/jjab026
28
Jeffrey D. McCurdy, Javeria Munir, Simon Parlow, Jacqueline Reid, Russell Yanofsky, Talal Alenezi, Joseph Meserve, Brenda Becker, Zubin Lahijanian, Anas Hussam Eddin, Ranjeeta Mallick, Tim Ramsay, Greg Rosenfeld, Ali Bessissow, Talat Bessissow, Vipul Jairath, Siddharth Singh, David H. Bruining, Blair Macdonald. Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn’s Disease: A Multicenter Study. Clinical Gastroenterology and Hepatology 2024; 22(5) doi: 10.1016/j.cgh.2023.12.006
29
Etienne Buscail, Guillaume Le Cosquer, Fabian Gross, Marine Lebrin, Laetitia Bugarel, Céline Deraison, Nathalie Vergnolle, Barbara Bournet, Cyrielle Gilletta, Louis Buscail. Adipose-Derived Stem Cells in the Treatment of Perianal Fistulas in Crohn’s Disease: Rationale, Clinical Results and Perspectives. International Journal of Molecular Sciences 2021; 22(18) doi: 10.3390/ijms22189967
30
Fabian Juliao-Baños, Carlos Fernando Grillo A, Luis Fernando Pineda Ovalle, William Otero Regino. , María Teresa Galiano de Sánchez. , Rafael García Duperly. , María Teresa Vallejo O. , Marcela Torres Amaya. . Guía de práctica clínica para el tratamiento de la enfermedad de Crohn en población adulta . Revista Colombiana de Gastroenterología 2020; 35(Supl. 2) doi: 10.22516/25007440.637
31
Nadia Fathallah, Cosmin Cristea, Hélène Beaussier, Sonia Khirani, Vincent de Parades. Infliximab for Anoperineal Lesions in Crohn's Disease: Remission Appears to be Based on Rapid Combination Therapy at High Doses. Journal of Coloproctology 2022; 42(02) doi: 10.1055/s-0041-1739549
32
Wan-Ting Cao, Rong Huang, Ke-Fang Jiang, Xue-Hui Qiao, Jing-Jing Wang, Yi-Hong Fan, Yi Xu. Predictive value of blood concentration of biologics on endoscopic inactivity in inflammatory bowel disease: A systematic review. World Journal of Gastroenterology 2021; 27(9): 886-907 doi: 10.3748/wjg.v27.i9.886
33
Nahla Azzam, Othman Alharbi, Majid Almadi, Abdulrahman Aljebreen, Turki AlAmeel, Mohammed Alabbas, Salman Bahammam, Ahmed Bashmail, Yasser Alomar, Mahmoud Mosli. Predictors of long-term outcomes of radiologically defined perianal fistulizing Crohn’s disease treated with antitumor necrosis factor-alpha agents based on Parks’ classification. European Journal of Gastroenterology & Hepatology 2020; 32(2) doi: 10.1097/MEG.0000000000001634
34
Torsten Kucharzik, Jeroen Tielbeek, Dan Carter, Stuart A Taylor, Damian Tolan, Rune Wilkens, Robert V Bryant, Christine Hoeffel, Isabelle De Kock, Christian Maaser, Giovanni Maconi, Kerri Novak, Søren R Rafaelsen, Martina Scharitzer, Antonino Spinelli, Jordi Rimola. ECCO-ESGAR Topical Review on Optimizing Reporting for Cross-Sectional Imaging in Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2022; 16(4) doi: 10.1093/ecco-jcc/jjab180
35
Konstantinos Papamichael, Adam S Cheifetz. Defining and predicting deep remission in patients with perianal fistulizing Crohn’s disease on anti-tumor necrosis factor therapy. World Journal of Gastroenterology 2017; 23(34): 6197-6200 doi: 10.3748/wjg.v23.i34.6197
36
Jong Lyul Lee, Yong Sik Yoon, Chang Sik Yu. Treatment Strategy for Perianal Fistulas in Crohn Disease Patients: The Surgeon’s Point of View. Annals of Coloproctology 2021; 37(1) doi: 10.3393/ac.2021.02.08
37
Shi-Si Ding, Chang Liu, Guan-Qun Zhang, Wei-Wei Ren, Hui Zhao, Qian Zhang, Hao-Qiang Yin, Li-Ping Sun, Hui-Xiong Xu. Development and validation of a predictive model for early failure of biological therapy in perianal fistulizing Crohn’s disease based on three-dimensional transrectal ultrasound. Inflammatory Bowel Diseases 2026; 32(8) doi: 10.1093/ibd/izag048